16 research outputs found

    Are changes in the breast during hormone replacement therapy (HRT) a risk factor for breast cancer?

    Get PDF

    Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients Results after 5 years of follow-up

    No full text
    International audienceAxillary lymph node clearance (ALNC) improves locoregional control and provides prognostic information for early breast cancer treatment, but effects on survival are controversial. This multicentre, randomized pragmatic equivalence trial compares outcomes for post-menopausal early invasive breast cancer patients after locoregional treatment with ALNC and adjuvant therapies to outcomes after locoregional treatment without ALNC and adjuvant therapies
    corecore